AstraZeneca analysed rare variant contribution to human disease
Drug Discovery Today
SEPTEMBER 22, 2021
AstraZeneca scientists, based in Cambridge UK, have analysed over 18,000 phenotypes in combination with whole exome sequencing data from nearly 300,000 UK Biobank research participants.
Let's personalize your content